Skip to main content
. 2017 Jan 26;16(1):62–76. doi: 10.1002/wps.20386

Table 1.

Demographic and clinical characteristics of youth at Time 1 and Time 2

Persistent, P (N=128) Resilient, R (N=121) Emergent, E (N=42) Typically Developing, T (N=212) p Pairwise
Age, years (mean±SD)
Time 1 15.5 ± 2.5 15.0 ± 2.5 14.7 ± 2.9 14.8 ± 2.8 n.s.
Time 2 17.5 ± 2.6 17.1 ± 2.8 16.7 ± 2.9 16.6 ± 3.7 n.s.
Follow‐up interval, months (mean±SD) 23.2 ± 7.9 25.8 ± 7.3 23.7 ± 5.3 23.2 ± 6.7 0.009 R>P,T
Male/female 61/67 55/66 22/20 100/112 n.s.
African‐American/Other (%) 76.6 63.6 76.2 42.5 0.001 P>R,T
R>T
E>T
Parental education, years (mean±SD)
Mother 13.2 ± 3.4 12.7 ± 4.9 12.5 ± 4.4 13.7 ± 4.6 n.s.
Father 10.9 ± 5.6 11.7 ± 5.3 11.1 ± 5.2 12.2 ± 6.1 n.s.
Neighborhood socioeconomic status factor score (mean±SD) −0.6 ± 1.0 −0.4 ± 1.0 −0.6 ± 1.0 0.0 ± 1.0 0.001 P,R,E<T
Time 1 psychopathology factor scores (mean±SD)
Psychosis 1.4 ± 0.9 1.0 ± 0.8 −0.2 ± 1.0 −0.6 ± 0.8 0.001 P>R,E,T
R>E,T
E>T
Anxious‐Misery 1.1 ± 0.9 0.7 ± 0.9 −0.1 ± 1.0 −0.6 ± 0.9 0.001 P>R,E,T
R>E,T
E>T
Fear 0.9 ± 1.0 0.6 ± 1.0 −0.1 ± 1.1 −0.6 ± 0.9 0.001 P>R,E,T
R>E,T
E>T
Externalizing 0.8 ± 0.8 0.6 ± 0.8 0.0 ± 1.1 −0.6 ± 0.8 0.001 P,R>E,T
E>T
Time 1 PRIME‐Screen Revised, total (mean±SD) 24.8 ± 14.0 18.4 ± 12.4 6.4 ± 7.4 2.4 ± 4.9 0.001 P>R,E,T
R>E,T
E>T
Time 1 PRIME‐Screen Revised, z (mean±SD) 1.6 ± 1.4 1.0 ± 1.2 −0.1 ± 0.7 −0.4 ± 0.5 0.001 P>R,E,T
R>E,T
E>T
Time 1 Scale of Prodromal Symptoms, z (mean±SD) 1.1 ± 1.5 0.6 ± 1.4 −0.1 ± 0.8 −0.5 ± 0.4 0.001 P>R,E,T
R>E,T
E>T
Time 1 Trauma exposure (mean±SD) 1.6 ± 1.5 1.2 ± 1.3 1.0 ± 1.1 0.5 ± 0.8 0.001 P>R,E,T
R, E>T
Time 1 Global Assessment Scale (mean±SD) 69.3 ± 13.4 76.5 ± 11.4 80.4 ± 10.2 85.7 ± 7.7 0.001 P<R,E,T
R<E,T
E<T
Time 1 treatment (%)
Talked with professional 68.8 54.2 45.2 34.1 0.001 P>R,E,T
R>T
Psychiatric medications 23.4 11.9 4.8 2.4 0.001 P>R,E,T
R>T
Inpatient hospitalizations 7.8 1.7 2.4 0.9 0.003 P>R,T
Time 2 diagnosis (%)
Psychotic disorder 13.3 0.0 4.8 0.0 0.001 P>R,T
E>R,T
Major depressive disorder 18.8 13.2 16.7 3.8 0.001 P,R,E>T
Other mood disorder 15.6 2.5 4.8 3.3 0.001 P>R,T
Attention‐deficit/hyperactivity disorder 21.9 9.9 7.1 4.7 0.001 P>R,E,T
Alcohol abuse 7.0 1.7 4.8 1.4 0.023 P>R,T
Alcohol dependence 3.1 1.7 0.0 1.4 n.s.
Substance abuse 8.6 4.1 4.8 0.9 0.006 P>T
Substance dependence 6.3 5.0 2.4 1.9 n.s.
Time 2 Scale of Prodromal Symptoms, total (mean±SD)
Positive 9.6 ± 5.2 2.4 ± 2.5 7.4 ± 4.5 1.6 ± 2.2 0.001 P>R,E,T
R>T
E>R,T
Negative 7.6 ± 5.2 3.2 ± 3.4 7.3 ± 4.9 1.7 ± 2.3 0.001 P>R,T
R>T
E>R,T
Disorganized 4.6 ± 3.3 1.3 ± 1.7 3.4 ± 2.5 0.7 ± 1.3 0.001 P>R,E,T
R>T
E>R,T
General 4.0 ± 3.4 1.2 ± 2.2 4.2 ± 3.0 1.2 ± 1.9 0.001 P>R,T
R>T
E>R,T
Time 2 Mini‐Mental State Examination (mean±SD) 31.4 ± 3.4 32.1 ± 2.3 31.5 ± 3.2 32.3 ± 2.2 0.001 P,E<T
Time 2 Global Assessment of Functioning (mean±SD) 59.7 ± 10.4 77.1 ± 13.1 64.6 ± 11.4 83.4 ± 10.0 0.001 P<R,E,T
R<T
E<R,T
Time 2 treatment history (%)
Talked with professional 76.8 46.5 48.6 30.8 0.001 P>R,E,T
R>T
E>T
Psychiatric medications 22.3 8.0 18.2 4.7 0.001 P>R,T
E>T
Inpatient hospitalization 11.5 3.4 10.8 1.0 0.001 P>R,T
E>T
Time 2 family history of psychosis (%) 22.6 7.7 8.3 3.1 0.001 P>R,T